In short
Docetaxel, also known by its brand name Taxotere, is a chemotherapy drug being studied in various clinical trials for the treatment of different types of cancer. These trials aim to evaluate its effectiveness, safety, and potential combinations with other drugs to improve outcomes for patients with advanced solid tumors, breast cancer, and other malignancies.
At a glance
- Drug Name
- Docetaxel (Taxotere)
- Cancer Types Studied
- Advanced breast cancer, gastric cancer, non-small cell lung cancer, solid tumors
- Administration Method
- Intravenous (IV) infusion
- Common Dosage
- 75-100 mg/m² every 3 weeks (may vary by trial)
- Combination Therapies
- Capecitabine, Cisplatin, Herceptin (Trastuzumab)
- Primary Outcomes Measured
- Tumor response rate, progression-free survival, overall survival
- Secondary Outcomes
- Safety profile, quality of life, pharmacokinetics
- Biomarker Studies
- Gene expression profiling to predict treatment response
What is Docetaxel?
Docetaxel is a powerful chemotherapy drug used to treat various types of cancer. It's also known by its brand name Taxotere. Docetaxel belongs to a class of drugs called taxanes, which are derived from yew trees and work by interfering with cell division.
What Conditions Does Docetaxel Treat?
Docetaxel is used to treat several types of cancer, including:
- Breast cancer: It's used in both early-stage and advanced breast cancer
- Non-small cell lung cancer: Docetaxel is used as a second-line treatment for this type of lung cancer
- Prostate cancer: It's used in combination with other treatments for high-risk localized prostate cancer
- Gastric (stomach) cancer: Docetaxel is used in combination with other drugs for advanced gastric cancer
- Head and neck cancers: It's being studied for use in nasopharyngeal carcinoma, a type of head and neck cancer
- Germ cell cancers: Docetaxel is being investigated for use in recurrent or refractory germ cell cancers
How Does Docetaxel Work?
Docetaxel works by interfering with the way cancer cells divide and grow. Specifically, it:
- Stops cancer cells from dividing, which prevents them from growing or causes them to die
- May also affect the blood vessels that feed tumors, potentially slowing their growth
How is Docetaxel Administered?
Docetaxel is typically given as an intravenous (IV) infusion, which means it's delivered directly into your bloodstream through a vein. The specific administration details can vary depending on the type of cancer and treatment plan, but generally:
- It's often given once every 3 weeks, in what's called a treatment cycle
- The infusion usually takes about 1 hour
- The dose is typically calculated based on your body surface area (which takes into account your height and weight)
Potential Side Effects
Like all chemotherapy drugs, docetaxel can cause side effects. Some common side effects may include:
- Lowered blood cell counts, which can increase risk of infection or bleeding
- Nausea and vomiting
- Hair loss
- Fatigue
- Diarrhea
- Mouth sores
Your healthcare team will monitor you closely for these and other side effects and can provide treatments to help manage them.
Ongoing Research and Clinical Trials
Researchers continue to study docetaxel to find new ways to use it effectively. Some areas of ongoing research include:
- Combining docetaxel with newer immunotherapy drugs for prostate cancer
- Using docetaxel before surgery (neoadjuvant therapy) in breast cancer to shrink tumors
- Combining docetaxel with other chemotherapy drugs for gastric cancer
- Testing docetaxel as part of treatment regimens for nasopharyngeal carcinoma
These studies aim to improve the effectiveness of docetaxel and find new ways to use it to help more patients with cancer.